ACHEMA 2012
If you?re heading to Frankfurt for the ACHEMA trade show (taking place 18?22 June), we suggest you take a look at our quick guide to help you get your head around this behemoth of a show.
ACHEMA 2012 has begun! Thousands of people from all over the world are expected to gather at the Messe Frankfurt in Germany to forge new partnerships and to discuss the latest trends in the processing industries, including the pharmaceutical and biopharmaceutical sectors.
This year, the majority of the PTE team is attending the show in Frankfurt in Hall 3.1, Stand J25. You are more than welcome to visit us to let us know what's happening in your corner of the market, or to tell us about something exciting you've seen.
We will be active online during the show, providing daily blogs and feeding important news through our twitter account. If you're not already a follower, and especially if you're not able to attend the show but want to be kept up-to-date, then head to http://PharmTech.com/twitter to join us.
To receive our special ACHEMA eshow daily and our regular e-newsletter, subscribe here.
You can let us know how ACHEMA is progressing for you by filling out this quick form.
This page will be updated with all the latest ACHEMA information so check back soon!
Live: ACHEMA Opening Day Report
More Than Nintey Years of ACHEMA?!
ACHEMA 2012 on the Home Stretch
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
